| Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1760 | 2021 |
| Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of … TM Uyeki, HH Bernstein, JS Bradley, JA Englund, TM File, AM Fry, ... Clinical Infectious Diseases 68 (6), e1-e47, 2019 | 886 | 2019 |
| A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus WA Fischer, JJ Eron Jr, W Holman, MS Cohen, L Fang, LJ Szewczyk, ... Science translational medicine 14 (628), eabl7430, 2021 | 286 | 2021 |
| Molnupiravir, an oral antiviral treatment for COVID-19 W Fischer, JJ Eron Jr, W Holman, MS Cohen, L Fang, LJ Szewczyk, ... MedRxiv, 2021.06. 17.21258639, 2021 | 227 | 2021 |
| Coronavirus disease 2019: implications of emerging infections for transplantation MG Michaels, RM La Hoz, L Danziger-Isakov, EA Blumberg, D Kumar, ... American Journal of Transplantation 20 (7), 1768-1772, 2020 | 219 | 2020 |
| Decontamination and reuse of N95 respirators with hydrogen peroxide vapor to address worldwide personal protective equipment shortages during the SARS-CoV-2 (COVID-19) pandemic A Schwartz, M Stiegel, N Greeson, A Vogel, W Thomann, M Brown, ... Applied Biosafety 25 (2), 67-70, 2020 | 217 | 2020 |
| In Vitro Activity of Amikacin against Isolates of Mycobacterium avium Complex with Proposed MIC Breakpoints and Finding of a 16S rRNA Gene Mutation in Treated … BA Brown-Elliott, E Iakhiaeva, DE Griffith, GL Woods, JE Stout, CR Wolfe, ... Journal of clinical microbiology 51 (10), 3389-3394, 2013 | 156 | 2013 |
| Severe monkeypox in hospitalized patients—United States, August 10–october 10, 2022 MJ Miller MMWR. Morbidity and mortality weekly report 71, 2022 | 144 | 2022 |
| Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial AC Kalil, AK Mehta, TF Patterson, N Erdmann, CA Gomez, MK Jain, ... The lancet respiratory medicine 9 (12), 1365-1376, 2021 | 141 | 2021 |
| Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation AW Baker, SS Lewis, BD Alexander, LF Chen, RJ Wallace Jr, ... Clinical Infectious Diseases 64 (7), 902-911, 2017 | 132 | 2017 |
| Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial RT Davey, E Fernández-Cruz, N Markowitz, S Pett, AG Babiker, ... The Lancet Respiratory Medicine 7 (11), 951-963, 2019 | 126 | 2019 |
| Implementation of a pooled surveillance testing program for asymptomatic SARS-CoV-2 infections on a college campus—Duke University, Durham, North Carolina, August 2–October 11 … TN Denny MMWR. Morbidity and mortality weekly report 69, 2020 | 117 | 2020 |
| Donor-derived transmission events in 2013: a report of the organ procurement transplant network ad hoc disease transmission advisory committee M Green, S Covington, S Taranto, C Wolfe, W Bell, SW Biggins, D Conti, ... Transplantation 99 (2), 282-287, 2015 | 116 | 2015 |
| Effect of P2Y12 inhibitors on survival free of organ support among non–critically ill hospitalized patients with COVID-19: a randomized clinical trial JS Berger, LZ Kornblith, MN Gong, HR Reynolds, M Cushman, Y Cheng, ... Jama 327 (3), 227-236, 2022 | 102 | 2022 |
| Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients—North Carolina, 2009 LF Chen, NJM Dailey, AK Rao, AT Fleischauer, I Greenwald, VM Deyde, ... Journal of Infectious Diseases 203 (6), 838-846, 2011 | 99 | 2011 |
| Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial CR Wolfe, KM Tomashek, TF Patterson, CA Gomez, VC Marconi, MK Jain, ... The lancet respiratory medicine 10 (9), 888-899, 2022 | 87 | 2022 |
| Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised … JH Beigel, Y Bao, J Beeler, W Manosuthi, A Slandzicki, SM Dar, J Panuto, ... The Lancet infectious diseases 17 (12), 1255-1265, 2017 | 87 | 2017 |
| Use of letermovir as salvage therapy for drug-resistant cytomegalovirus retinitis N Turner, A Strand, DS Grewal, G Cox, S Arif, AW Baker, EK Maziarz, ... Antimicrobial agents and chemotherapy 63 (3), 10.1128/aac. 02337-18, 2019 | 86 | 2019 |
| donor‐derived infections: guidelines from the American society of transplantation infectious diseases community of practice CR Wolfe, MG Ison, AST Infectious Diseases Community of Practice Clinical Transplantation 33 (9), e13547, 2019 | 85 | 2019 |
| The “PHS Increased Risk” label is associated with nonutilization of hundreds of organs per year ML Volk, AR Wilk, C Wolfe, DR Kaul Transplantation 101 (7), 1666-1669, 2017 | 82 | 2017 |
